<?xml version="1.0" encoding="UTF-8"?>
<p>None of the developed vaccines against CoVs have yet been approved. However, hope in reaching effective vaccine against SARS-CoV-2 still exists to strengthen immunity and reduce related symptoms. 
 <xref rid="T1" ref-type="table">Table 1</xref> shows different vaccine platforms used against CoVs. Vaccination can be achieved either through exposing the body to antigens such as live-attenuated virus [
 <xref rid="B45" ref-type="bibr">45–47</xref>], inactivated virus or recombinant viral parts (DNA, mRNA and proteins) or through exposing the body directly to neutralizing antibodies [
 <xref rid="B6" ref-type="bibr">6</xref>,
 <xref rid="B11" ref-type="bibr">11</xref>,
 <xref rid="B17" ref-type="bibr">17</xref>,
 <xref rid="B20" ref-type="bibr">20</xref>,
 <xref rid="B48" ref-type="bibr">48</xref>].
</p>
